Cancer of the prostate is the commonest noncutaneous cancer amongst men in the Republic of Ireland. It represents 11% of all male cancers. The risk of developing prostate cancer before the age of 75 is 5% and has increased by 1.3% since 1994. The disease-specific risk of death before 75 is 1.6%. Approximately five hundred and twenty men die of carcinoma of the prostate per annum. The aims of these guidelines are to increase awareness of prostate cancer in the Irish community. The guidelines provide a source of information, the ultimate aim of which is to facilitate and promote optimum care for patients presenting with carcinoma of the prostate. By reference to the guidelines and enactment of the recommendations disease-free intervals and increased survival in patients with prostatic cancer may be achieved. In publishing the guidelines we aspire to inform clinicians about best clinical practice. Promotion of best available standards should lead to the elimination of the unacceptable. The guidelines are not intended to be rigidly dogmatic and are not written as protocols. Clinical freedom is preserved within the limits of good practice. Ultimately it is hoped that the guidelines will lead to better uniform care throughout the country with improvement in survival for all patients with prostate cancer.
Medicine and Health Sciences | Surgery
Clinical Guidelines Committee. Prostate Cancer Management Clinical Guidelines. Dublin: Royal College of Surgeons in Ireland, 2002.